Docosahexaenoic Acid Serum Levels in Patients With Preeclampsia

NCT05591638 | Unknown

• 1 other identifier: 2022/169
• Study Type: observational
• Target: 90
• Locations: 0 countries
• Sites: N/A

Brief Summary

By comparing the blood levels of docosahexaenoic acid (DHA) in preeclamptic patients with normal pregnant women, we aim to reveal the relationship between these markers, which are known to be effective on metabolic function, and preeclampsia, and to contribute to future studies and possible treatment options

Conditions

Preeclampsia

Keywords

Preeclampsia; docosahexaenoic acid; fatty acids; omega-3

Outcome Measures

Primary Outcomes (1)

• docosahexaenoic acid

  docosahexaenoic acid levels between groups will be measured

  6 months

Study Arms (2)

GROUP 1

There will be 45 patients diagnosed with preeclampsia in the study group

GROUP 2

There will be 45 normal pregnant women in the control group

Eligibility Criteria

• Age: 18 Years - 40 Years
• Sex: female
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

18-40 years old pregnant women at 20-40 weeks of gestation with and without preeclampsia (study and control)

You may qualify if:

• Pregnant women between the ages of 18-40, singleton pregnancies, pregnant women with preeclampsia, healthy pregnant women who do not have a history of hypertension before and after pregnancy

You may not qualify if:

• Pregnant women diagnosed with chronic hypertension before pregnancy, pregnant women with hypertension before the 20th gestational week, multiple pregnancies, pregnant women with molar pregnancies, women with a body mass index (BMI) \>30kg/m2, pregnant women with a history of birth complicated with chromosomal abnormalities, pre-pregnancy or during pregnancy Pregnant women diagnosed with diabetes mellitus, pregnant women diagnosed with chronic systemic diseases, especially rheumatological, renal and vascular diseases, pregnant women diagnosed with chorioamnionitis, pregnant women with polyhydramnios, maternal infection diagnosis

Sponsors & Collaborators

• Recep Tayyip Erdogan University Training and Research Hospital: lead

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-Induced; Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases

Study Officials

• SENOL SENTURK

  Recep Tayyip Erdogan University

  STUDY DIRECTOR

Central Study Contacts

SENOL SENTURK

CONTACT

+905327166482; dr.senturk@hotmail.com

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate professor

Study Record Dates

• First Submitted: October 19, 2022
• First Posted: October 24, 2022
• Study Start: October 24, 2022
• Primary Completion: April 30, 2023
• Study Completion: May 30, 2023
• Last Updated: October 24, 2022

Record last verified: 2022-10